Uddin MS

References (10)

Title : Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets - Uddin_2021_Mol.Neurobiol_58_281
Author(s) : Uddin MS , Al Mamun A , Kabir MT , Ashraf GM , Bin-Jumah MN , Abdel-Daim MM
Ref : Molecular Neurobiology , 58 :281 , 2021
PubMedID: 32935230

Title : Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects - Rahman_2021_Molecules_27_
Author(s) : Rahman MM , Rahaman MS , Islam MR , Rahman F , Mithi FM , Alqahtani T , Almikhlafi MA , Alghamdi SQ , Alruwaili AS , Hossain MS , Ahmed M , Das R , Emran TB , Uddin MS
Ref : Molecules , 27 : , 2021
PubMedID: 35011465

Title : Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential - Javaid_2021_Curr.Pharm.Des_27_3591
Author(s) : Javaid N , Shah MA , Rasul A , Chauhdary Z , Saleem U , Khan H , Ahmed N , Uddin MS , Mathew B , Behl T , Blundell R
Ref : Curr Pharm Des , 27 :3591 , 2021
PubMedID: 33183192

Title : Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer's Disease - Uddin_2020_Curr.Pharm.Des__
Author(s) : Uddin MS , Kabir MT , Rahman MH , Alim MA , Rahman MM , Khatkar A , Al Mamun A , Rauf A , Mathew B , Ashraf GM
Ref : Curr Pharm Des , : , 2020
PubMedID: 32250219

Title : Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease - Uddin_2020_Molecules_25_1267
Author(s) : Uddin MS , Kabir MT , Niaz K , Jeandet P , Clement C , Mathew B , Rauf A , Rengasamy KRR , Sobarzo-Sanchez E , Ashraf GM , Aleya L
Ref : Molecules , 25 :1267 , 2020
PubMedID: 32168835

Title : Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning - Kabir_2019_Curr.Pharm.Des_25_3519
Author(s) : Kabir MT , Uddin MS , Begum MM , Thangapandiyan S , Rahman MS , Aleya L , Mathew B , Ahmed M , Barreto GE , Ashraf GM
Ref : Curr Pharm Des , 25 :3519 , 2019
PubMedID: 31593530

Title : Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases - Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
Author(s) : Mathew B , Parambi DGT , Mathew GE , Uddin MS , Inasu ST , Kim H , Marathakam A , Unnikrishnan MK , Carradori S
Ref : Arch Pharm (Weinheim) , :e1900177 , 2019
PubMedID: 31478569

Title : Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole - Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
Author(s) : Mathew B , Baek SC , Thomas Parambi DG , Lee JP , Mathew GE , Jayanthi S , Vinod D , Rapheal C , Devikrishna V , Kondarath SS , Uddin MS , Kim H
Ref : Arch Pharm (Weinheim) , :e1800309 , 2019
PubMedID: 30663112

Title : Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review - Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
Author(s) : Mathew B , Parambi DGT , Sivasankarapillai VS , Uddin MS , Suresh J , Mathew GE , Joy M , Marathakam A , Gupta SV
Ref : CNS Neurol Disord Drug Targets , 18 :432 , 2019
PubMedID: 31187716

Title : Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease - Uddin_2016_Ann.Neurosci_23_218
Author(s) : Uddin MS , Al Mamun A , Hossain MS , Akter F , Iqbal MA , Asaduzzaman M
Ref : Ann Neurosci , 23 :218 , 2016
PubMedID: 27780989